
Nipro Corporation
8086.TJPXHealthcareMedical - Instruments & Supplies
Latest quote
¥1,590.5
+¥4.50 · +0.28%
8086.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteNipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development, production, and distribution of an extensive selection of disposable medical products. These offerings encompass specialized items for renal treatment, interventional procedures and anesthesia, injection and infusion therapies, dialysis, cardiopulmonary support, diabetes management, and cell culture applications. This division also markets products associated with artificial organs, as well as generic and kit-based medical supplies. Within its Pharmaceutical division, Nipro delivers innovative pharmaceutical combination products, such as dual chamber bags, pre-filled syringes, and half-type kits. It further extends its services through contract manufacturing for orally administered medications, injectable solutions, and topical preparations. The Pharma Packaging segment is focused on providing a comprehensive array of glass packaging solutions. This includes vials, ampoules, syringes, cartridges, and glass tubes. Additionally, this division manufactures glass forming machinery, glass bulbs for vacuum flasks, and various other essential pharmaceutical packaging components, such as rubber stoppers. An 'Other' business activity involves the provision of thermostable enzymes, which are vital for clinical chemistry applications. Nipro also offers business management services. Established in Osaka, Japan, in 1947, Nipro Corporation now serves a wide international customer base, spanning Japan, the Americas, Europe, and other regions across Asia.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Yoshihiko Sano
- Listed since
- Jan 1, 2001
- Employees
- 38,593
Market position
- Volume
- 0
- 0× average
- Average volume
- 706.5K
- Average daily volume
- Market cap
- 259.4B JPY
- Beta
- -0.01
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 793.6B JPY
- P/E (TTM)
- 18.45×
- P/B (TTM)
- 0.92×
- P/S (TTM)
- 0.39×
- EV / EBITDA
- 7.71×
- Earnings yield
- 5.33%
- Free cash flow yield
- -3.03%
- Dividend yield
- 1.82%
Profitability & efficiency
- Gross margin
- 31.71%
- Operating margin
- 5.70%
- Net margin
- 2.10%
- Return on equity
- 4.93%
- Return on assets
- 1.11%
- Return on invested capital
- 1.98%
Financial health
- Debt / equity
- 2.34×
- Current ratio
- 1.39×
- Altman Z-score
- 1.12
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 660.54B JPY | 644.59B JPY | 586.79B JPY | 545.2B JPY | 494.79B JPY |
| Cost of goods sold | 452.26B JPY | 450.93B JPY | 412.81B JPY | 379.3B JPY | 342.95B JPY |
| Gross profit | 208.28B JPY | 193.66B JPY | 173.98B JPY | 165.9B JPY | 151.84B JPY |
| Research and development | — | 21.67B JPY | 20.85B JPY | 19.67B JPY | 18.73B JPY |
| Selling, general, and administrative | 170.66B JPY | 145.39B JPY | 130.8B JPY | 128.5B JPY | 109.22B JPY |
| Operating expenses | 170.66B JPY | 167.06B JPY | 151.64B JPY | 148.17B JPY | 127.95B JPY |
| Interest income | 2.21B JPY | 2.18B JPY | 1.58B JPY | 1.1B JPY | 669M JPY |
| Interest expense | 9.77B JPY | 7.84B JPY | 6.53B JPY | 4.5B JPY | 4.19B JPY |
| Depreciation and amortization | 63.74B JPY | 65.65B JPY | 58.87B JPY | 48.74B JPY | 46.16B JPY |
| Operating income | 37.63B JPY | 26.6B JPY | 22.34B JPY | 17.73B JPY | 23.88B JPY |
| Net income | 13.5B JPY | 5.11B JPY | 11.11B JPY | 4.58B JPY | 13.46B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -15.08%
- 11 comparable reports
- Latest EPS result
- 23.48
- Estimate 14.17 · Beat by 65.70%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
8086.T peers
ETFs holding 8086.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T674.05M0.02%2.89T JPY0.05%¥417.7-0.07%
Avantis International Small Cap Value ETFAVDV45.37M0.22%20.24B USD0.36%$111.83-0.11%
Vanguard Total International Stock ETFVXUS22.36M0.00%646.2B USD0.05%$87.20-0.58%
Vanguard FTSE Developed Markets ETFVEA15.14M0.00%315B USD0.03%$73.06-0.49%
iShares Core MSCI EAFE ETFIEFA11.23M0.01%195.14B USD0.07%$100.67-0.18%
iShares MSCI EAFE Small-Cap ETFSCZ5.4M0.04%13.28B USD0.40%$86.50-0.12%
Dimensional - International Small Cap Value ETFDISV4.64M0.09%5.23B USD0.42%$44.48-0.02%
Schwab International Equity ETFSCHF3.57M0.01%69.7B USD0.03%$28.32-0.49%
iShares Core TOPIX ETF1475.T- Market value
- 674.05M
- Weight
- 0.02%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥417.7-0.07%
Avantis International Small Cap Value ETFAVDV- Market value
- 45.37M
- Weight
- 0.22%
- AUM
- 20.24B USD
- Expense ratio
- 0.36%
- Price / 1D
- $111.83-0.11%
Vanguard Total International Stock ETFVXUS- Market value
- 22.36M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.20-0.58%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 15.14M
- Weight
- 0.00%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.06-0.49%
iShares Core MSCI EAFE ETFIEFA- Market value
- 11.23M
- Weight
- 0.01%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.67-0.18%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 5.4M
- Weight
- 0.04%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.50-0.12%
Dimensional - International Small Cap Value ETFDISV- Market value
- 4.64M
- Weight
- 0.09%
- AUM
- 5.23B USD
- Expense ratio
- 0.42%
- Price / 1D
- $44.48-0.02%
Schwab International Equity ETFSCHF- Market value
- 3.57M
- Weight
- 0.01%
- AUM
- 69.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $28.32-0.49%
Continue in GoAI
Research 8086.Tresearch.disclaimer





